drugset / Trial / NCT03208985
A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions
NaSingle-groupOpen-labelOther
Summary
This study is designed to assess whether consumers select and use ella® (ulipristal acetate 30mg), an emergency contraceptive, in a manner consistent with the OTC package directions in an OTC-like setting.
Timeline
- Start
- 2017-05-23
- Primary completion
- 2018-06-14
- Completion
- 2018-06-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ulipristal Acetate | Unknown | 30 mg | — |
Indications
No indication recorded.